Vipergen Establishes DNA Encoded Library (DEL)-Based Drug Discovery Partnership with Theseus Pharmaceuticals Focused on Targeted Cancer Therapies

Vipergen, a leading provider of small-molecule drug discovery services based on DNA-encoded library (DEL) technologies, announced today the signing of a drug discovery agreement with

Related Keywords

Japan ,Denmark ,Copenhagen ,Køavn ,Nils Hansen ,Vipergen Apsvipergen ,Mary Moynihan ,Prnewswire Vipergen ,Theseus Pharmaceuticals ,Chief Executive Officer ,Binder Trap Enrichment ,Cellular Binder Trap Enrichment ,Mary Moynihanm ,Vipergen ,Na ,Dancer ,Ealth Press Release ,